HypertensionNCT01952119
Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System
A study testing Secure message reminder in people with Hypertension, run by Kaiser Permanente at 1 site in United States.
Trial summary
This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Hypertension
- What is being tested?
- Secure message reminder
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 182 participants
- Where
- 1 siteUnited States
- Study dates
- Oct 2011to Jun 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Member of Kaiser Permanente Georgia Pharmacy Cardiac Risk Service (PCRS)
- 18-75 years of age
- Enrolled in http://kp.org
- Most recent documented blood pressure is greater than or equal to 140/90 mmHg
Who cannot join
- Most recent documented blood pressure is greater than or equal to 180/110 mmHg
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care Delivery System
This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.
Read the detailed description
Hypertension is one of the leading risk factors for cardiovascular disease. Optimizing blood pressure management can help prevent adverse cardiovascular outcomes. The National Committee for Quality Assurance (NCQA) defines blood pressure control as less than 140/90 mmHg. Per this definition, less than half of Americans with hypertension are considered controlled. Literature has been published describing several ways of improving blood pressure management, but results have been variable.
- Conditions
- Hypertension
- Being tested
- Secure message reminder
- Keywords
- hypertension
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Secure message reminderOther
Single secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure
| Study group | Role | What they receive |
|---|---|---|
| Routine Care | No intervention | Routine care, no intervention |
| Secure message reminder | Active comparator | Will receive a secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure Receives: Other: Secure message reminder |
What is being measured
The primary outcome is the main question the study is designed to answer.
Appointment with new blood pressure reading
Percentage of patients who complete an appointment with a new documented blood pressure reading within six weeks after distributing the secure message reminder
Measured: 6 weeks
Secondary outcomes (3)
New appointment with new blood pressure reading
Measured: 6 weeks
Existing appointment kept with new blood pressure reading
Measured: 6 weeks
Change in antihypertensive regimen
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Sep 2013 (estimated)
- Study startOct 2011
- Primary completionDec 2011
- Study completionJun 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for HypertensionStudies of the same condition, open and under way.
- More trials run by Kaiser PermanenteThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 182 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kaiser Permanente
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Alina Kuo, PharmD, Principal investigator, Kaiser Permanente Georgia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01952119
- Sponsor's protocol ID
- GA-11AKuo-01
- Status last verified
- Sep 2013
- First submitted
- 24 Sep 2013
- Last updated
- 27 Sep 2013
- Results posted
- No
Publications
Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD005182. doi: 10.1002/14651858.CD005182.pub4.
PubMed 20238338
Study at a glance
From the registry record, last updated by the sponsor on 27 Sep 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care Delivery System
- ClinicalTrials.gov ID
- NCT01952119
- Acronym / sponsor ID
- GA-11AKuo-01
- Conditions
- Hypertension
- Keywords
- hypertension
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 182 participants (actual)
- Lead sponsor
- Kaiser PermanenteUniversity, hospital or other
- Study start
- Oct 2011
- Primary completion
- Dec 2011 (actual)
- Study completion
- Jun 2012 (actual)
- First posted
- 27 Sep 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.
Detailed description
Hypertension is one of the leading risk factors for cardiovascular disease. Optimizing blood pressure management can help prevent adverse cardiovascular outcomes. The National Committee for Quality Assurance (NCQA) defines blood pressure control as less than 140/90 mmHg. Per this definition, less than half of Americans with hypertension are considered controlled. Literature has been published describing several ways of improving blood pressure management, but results have been variable.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Routine Care | No intervention | –Routine care, no intervention |
| Secure message reminder | Active comparator | Other: Secure message reminderWill receive a secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Member of Kaiser Permanente Georgia Pharmacy Cardiac Risk Service (PCRS)
- 18-75 years of age
- Enrolled in http://kp.org
- Most recent documented blood pressure is greater than or equal to 140/90 mmHg
Key exclusion criteria (1 listed)
- Most recent documented blood pressure is greater than or equal to 180/110 mmHg
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Secure message reminderSingle secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure | Other | Secure message reminder |
Primary outcome
Appointment with new blood pressure reading
Time frame: 6 weeks
Percentage of patients who complete an appointment with a new documented blood pressure reading within six weeks after distributing the secure message reminder
3 secondary outcomes
New appointment with new blood pressure reading
Time frame: 6 weeks
Existing appointment kept with new blood pressure reading
Time frame: 6 weeks
Change in antihypertensive regimen
Time frame: 6 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Sep 2013.
- Background: PubMed 20238338Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD005182. doi: 10.1002/14651858.CD005182.pub4.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alina Kuo, PharmD principal investigator
Kaiser Permanente Georgia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Secure message reminder in people with Hypertension, run by Kaiser Permanente at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Sep 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Appointment with new blood pressure reading (time frame: 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01952119, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2013.